Search

everythinglearnresearchcommunity

for

Search:↓

Forehead modification greatly increases the perception of femininity and is a safe procedure.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Hair loss linked to higher heart disease risk in both men and women.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.